Annuncio pubblicitario
Italia markets open in 2 hours 9 minutes

  • Dow Jones

    38.225,66
    +322,37 (+0,85%)
     

  • Nasdaq

    15.840,96
    +235,48 (+1,51%)
     

  • Nikkei 225

    38.236,07
    -37,98 (-0,10%)
     

  • EUR/USD

    1,0738
    +0,0010 (+0,10%)
     

  • Bitcoin EUR

    55.524,29
    +2.051,57 (+3,84%)
     

  • CMC Crypto 200

    1.284,57
    +13,83 (+1,09%)
     

  • HANG SENG

    18.413,79
    +206,66 (+1,14%)
     

  • S&P 500

    5.064,20
    +45,81 (+0,91%)
     

Optinose to Present at the 2023 Cantor Global Healthcare Conference

Optinose, Inc.
·1 minuto per la lettura
Optinose, Inc.
Optinose, Inc.

YARDLEY, Pa., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the 2023 Cantor Global Healthcare Conference on September 27, 2023 at 4:45 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531